|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 144.43 USD | +0.68% |
|
-0.42% | -20.92% |
| 10-14 | Axsome Shows Valuation Disconnect Ahead of Q3, RBC Says | MT |
| 10-08 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
ETFs positioned on Axsome Therapeutics, Inc.
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +13.67% | - | 5,739 M€ | |
| +1.60% | 4.89% | 8 M€ | |
| +7.13% | 2.52% | 222 M€ | |
| +20.28% | 2.47% | 258 M€ | |
| +30.36% | 2.2% | 107 M€ | |
| +26.85% | 2.1% | 1,631 M€ | |
| +15.69% | 2.03% | 520 M€ | |
| +19.07% | 1.89% | 130 M€ | |
| +26.92% | 0.72% | 1,260 M€ | |
| +6.15% | 0.71% | 8 M€ | |
| +10.69% | 0.65% | 937 M€ | |
| +13.51% | 0.63% | 9 M€ | |
| +28.57% | 0.62% | 78 M€ | |
| +28.50% | 0.62% | 1,079 M€ | |
| +28.94% | 0.58% | 9,953 M€ | |
| +27.38% | 0.56% | 81 M€ | |
| +7.47% | 0.54% | 600 M€ | |
| +8.13% | 0.53% | 462 M€ | |
| +20.38% | 0.49% | 13 M€ | |
| +8.90% | 0.49% | 15,028 M€ | |
| +8.81% | 0.43% | 1,568 M€ | |
| +15.66% | 0.42% | 968 M€ | |
| +20.35% | 0.4% | 6,480 M€ | |
| +10.47% | 0.4% | 54 M€ | |
| +13.90% | 0.35% | 4,317 M€ | |
| +3.98% | 0.32% | 12 M€ | |
| +10.76% | 0.3% | 90 M€ | |
| +13.96% | 0.29% | 90 M€ | |
| +15.47% | 0.28% | 1,095 M€ | |
| +1.78% | 0.28% | 186 M€ | |
| +22.41% | 0.27% | 195 M€ | |
| +5.37% | 0.26% | 9 M€ | |
| +13.08% | 0.26% | 1,540 M€ | |
| +13.47% | 0.26% | 82,179 M€ | |
| +9.11% | 0.25% | 18 M€ | |
| +13.28% | 0.23% | 34 M€ | |
| +11.85% | 0.22% | 520 M€ | |
| +17.78% | 0.22% | 205 M€ |
Employees
1,346
Sector
Pharmaceuticals
Calendar
- Stock Market
- Stocks
- AXSM Stock
- ETFs Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
